Back

Novel strategies to lower Lp(a) What are the emerging insights & therapies?

29 August 2020 (13:05 - 13:20)
Organised by:
Congress Presentation Part of: Lp(a), a new lipid frontier in CV risk management & target for therapy Lipids Open Access ESC Congress 2020

About the speaker

Photo
Professor Sotirios Tsimikas

University of California San Diego, La Jolla (United States of America)

4 More presentations in this session

Presentation thumbnail
Lp(a): The new kid in lipid management
Professor E. Stroes (Amsterdam, NL)
Video
Presentation thumbnail
Lp(a) as target in cardiovascular prevention: Why worry and how to assess?
Professor P. Kamstrup (Copenhagen, DK)
Video
Presentation thumbnail
ASCVD risk reduction for patients with high Lp(a) in 2020: is there a role for PCSK9 inhibition?
Professor V. Bittner (Birmingham, US)
Video
Presentation thumbnail
Discussion.
Professor E. Stroes (Amsterdam, NL)
Video

Access the full session

Session thumbnail
Lp(a), a new lipid frontier in CV risk management & target for therapy
Video

The Event

Event poster

ESC Congress 2020

29 August 2020 13:05 CET
You may be interested in
thumbnail
Webinar
Unmet needs in lipid management: treatment goals and how to achieve them
thumbnail
Webinar
Risk assessment and lipid management in primary prevention
thumbnail
Congress Presentation
State-of-the-art lecture on how to keep your arteries young by tackling dyslipidaemia

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources